SCHEMBL12784573

SCHEMBL12784573

C=C1N[C@]2(C(=O)NS(=O)(=O)NC3CC3)C[C@H]2/C=C\CCCCC[C@H](NC(=O)OC(C)(C)C)C(=C)N2CCC[C@@H]12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12808087 0.94 CYP3A4 (0.32) —
SCHEMBL8245227 0.87 ADRB3 (0.35) —
SCHEMBL12784601 0.87 ADRB3 (0.34) —
SCHEMBL12808491 0.86 F2 (0.34) —
SCHEMBL11976324 0.86 ADRB3 (0.35) —
SCHEMBL8247848 0.86 ADRB3 (0.35) —
SCHEMBL13059684 0.86 ADRB3 (0.35) —
SCHEMBL13059689 0.85 ADRB3 (0.35) —
SCHEMBL11976323 0.85 ADRB3 (0.35) —
SCHEMBL12784090 0.84 CTSB (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2305698-A2 Macrocyclic inhibitors of Hepatitis C virus replication Intermune, Inc. (US) 2011-04-06 — — EP disclosed
Send feedback